{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:00:34Z","timestamp":1792504834898,"version":"4.5.0"},"reference-count":17,"publisher":"American Society of Hematology","issue":"10","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Microclots have been associated with various conditions, including postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. They have been postulated to be amyloid-fibrin(ogen) aggregates, but their role as a prognostic biomarker remains unclear. To examine their possible clinical utility, blood samples were collected for the first 96 hours from critically ill patients (n\u00a0= 104) admitted to the intensive care unit (ICU). Detection was by staining platelet-poor plasma samples with thioflavin T and visualized by fluorescent microscopy. Image J software was trained to identify and quantify microclots, which were detected in 44 patients (42.3%) on ICU admission but not in the remaining 60 (57.7%) or the 20 healthy controls (0.0%). Microclots on admission to ICU were associated with a primary diagnosis of sepsis (microclots present in sepsis, 23\/44 [52.3%] vs microclots absent in sepsis, 19\/60 [31.7%]; P\u00a0= .044). Multicolor immunofluorescence demonstrated that microclots consisted of amyloid-fibrinogen aggregates, which was supported by proteomic analysis. Patients with either a high number or larger-sized microclots had a higher likelihood of developing disseminated intravascular coagulation (odds ratio [OR], 51.4; 95% confidence interval [CI], 6.3-6721.1; P\u00a0&amp;lt; .001) and had an increased probability of 28-day mortality (OR, 5.3; 95%\u00a0CI, 2.0-15.6; P &amp;lt; .001). This study concludes that microclots, as defined by amyloid-fibrin(ogen) aggregates, are potentially useful in identifying sepsis and predicting adverse coagulopathic and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012473","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:18:38Z","timestamp":1710951518000},"page":"2499-2508","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-913X","authenticated-orcid":false,"given":"Jeremy","family":"Schofield","sequence":"first","affiliation":[{"name":"1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom"},{"name":"2Roald Dahl Haemostasis and Thrombosis Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-2455","authenticated-orcid":false,"given":"Simon T.","family":"Abrams","sequence":"additional","affiliation":[{"name":"1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom"},{"name":"3Department of Haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-1136","authenticated-orcid":false,"given":"Rosalind","family":"Jenkins","sequence":"additional","affiliation":[{"name":"4Centre for Drug Safety Science Bioanalytical Facility, Liverpool Shared Research Facilities, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lane","sequence":"additional","affiliation":[{"name":"5Department of Medical Statistics, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozheng","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom"},{"name":"3Department of Haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-8883","authenticated-orcid":false,"given":"Cheng-Hock","family":"Toh","sequence":"additional","affiliation":[{"name":"1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom"},{"name":"2Roald Dahl Haemostasis and Thrombosis Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom"},{"name":"3Department of Haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"issue":"1","key":"2024052418502158400_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-022-01579-5","article-title":"Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC)","volume":"21","author":"Pretorius","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2024052418502158400_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s43856-023-00242-8","article-title":"Plasma from patients with pulmonary embolism show aggregates that reduce after anticoagulation","volume":"3","author":"Baker","year":"2023","journal-title":"Commun Med"},{"issue":"1","key":"2024052418502158400_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12933-022-01623-4","article-title":"Proteomics of fibrin amyloid microclots in long COVID\/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system","volume":"21","author":"Kruger","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2024052418502158400_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2024052418502158400_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMra1208626","article-title":"Bleeding and coagulopathies in critical care","volume":"370","author":"Hunt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2024052418502158400_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"8","key":"2024052418502158400_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"2024052418502158400_bib8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the International society on thrombosis and haemostasis: a 5-year overview","volume":"5","author":"Toh","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2024052418502158400_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BCJ20220016","article-title":"A\u00a0central role for amyloid fibrin microclots in long COVID\/PASC: origins and therapeutic implications","volume":"479","author":"Kell","year":"2022","journal-title":"Biochem J"},{"issue":"122","key":"2024052418502158400_bib10","doi-asserted-by":"crossref","first-page":"20160539","DOI":"10.1098\/rsif.2016.0539","article-title":"Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide","volume":"13","author":"Pretorius","year":"2016","journal-title":"J\u00a0R Soc Interface"},{"issue":"1","key":"2024052418502158400_bib11","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41598-019-39056-x","article-title":"Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation","volume":"9","author":"Page","year":"2019","journal-title":"Sci Rep"},{"issue":"25","key":"2024052418502158400_bib12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood.2023021166","article-title":"Rethinking coagulation: from enzymatic and cell-based reactions to a convergent model involving innate immune activation","volume":"142","author":"Yong","year":"2023","journal-title":"Blood"},{"issue":"10","key":"2024052418502158400_bib13","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.jtha.2023.07.012","article-title":"Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection","volume":"21","author":"Connors","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"15","key":"2024052418502158400_bib14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1042\/BCJ20230241","article-title":"Are fibrinaloid microclots a cause of autoimmunity in long covid and other post-infection diseases?","volume":"480","author":"Kell","year":"2023","journal-title":"Biochem J"},{"issue":"7","key":"2024052418502158400_bib15","first-page":"Cd015775","article-title":"Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition","volume":"7","author":"Fox","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2024052418502158400_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","article-title":"Fibrin formation, structure and properties","volume":"82","author":"Weisel","year":"2017","journal-title":"Subcell Biochem"},{"issue":"6","key":"2024052418502158400_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3343\/alm.2016.36.6.505","article-title":"Current pathological and laboratory considerations in the diagnosis of disseminated intravascular coagulation","volume":"36","author":"Toh","year":"2016","journal-title":"Ann Lab Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2499\/2226462\/blooda_adv-2023-012473-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2499\/2226462\/blooda_adv-2023-012473-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:50:35Z","timestamp":1716562235000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/10\/2499\/515373\/Microclots-as-defined-by-amyloid-fibrinogen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012473","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}